MAY 29, 2014 7:30 AM PDT

Is Cervical Cancer a preventable Disease in women? The role of HPV as a screening test.

Speaker
  • Professor of Pathology, Contract Staff - Clinical & Molecular Virology. Center of Pediatric Research, Cleveland Clinic, Cleveland, Ohio
    Biography
      Belinda Yen-Lieberman, Ph.D., is a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine. She is board certified in clinical virology (Am Society for Clinical Pathology). Dr. Yen-Lieberman received her Bachelor of Science degree in microbiology from Southern Illinois University and her Master of Science and Doctorate degrees in Immunology and biochemistry at the University of Arkansas, Fayetteville, Arkansas. She completed fellowships in clinical and cellular immunology at Case Western Reserve University and the Cleveland Clinic Foundation.

      Dr. Yen-Lieberman has authored over one hundred thirty articles for numerous medical journals on a wide range of topics involving viruses and infectious disease, including studies involving HIV, Hepatitis B , Hepatitis C and Influenza A vaccine, tests for herpes simplex types 1 and 2, and tuberculosis. For the past 24 years, she was the medical director of clinical and Molecular Virology and Serology in Department of Laboratory Medicine. Since July 2015, Dr. Yen-Lieberman is a contract staff in Lab Medicine and Center for Pediatric Research (as clinical virologist). She is responsible for teaching Pathology residents, medical students in CCLCM and students from Cleveland Clinic Medical Technology School. She also participates in various clinical trial studies and research projects including the role of respiratory viruses in childhood asthma.

    Abstract

    Human papillomavirus (HPV) is the primary cause of cervical cancer and more than 100 types of HPV have been identified. Detection of HPV from cervical samples is associated with a 250 times increased risk of high grade cervical neoplasm. Approximately 30 HPV types were reported to infect primarily the squamous epithelium of the lower anogenital tracts of men and women. Worldwide, Cervical Cancer is much more common particularly in countries without screening programs, with an estimated 530,000 new cases of the disease and 275,000 resultant deaths each year (Farlay J, et al. 2008 and Arbyn M, et al 2011). When cervical cancer screening programs have been introduced into communities, marked reductions in cervical cancer incidence have followed (Gustafsson L, et al 1997).

    Human Papillomavirus is one of the most common sexually transmitted infections (STI) in the United States in women, with approximately 6.2 million cases diagnosed annually. The American Cancer Society estimates that there will be 12,170 new cases of cervical cancer in the United States in 2012, with 4,220 deaths from the disease ( Siegel R et al. 2012).

    Learning Objectives:

    At the completion of the presentation, the learners should know:
    1. What is Human Papilloma virus (HPV)
    2. HPV is the primary causal factor of cervical cancer and cervical disease in Women
    3. HPV is one of the most common sexually transmitted infections the the USA
    4. HPV vaccines are available for young men and young women
    5. Why is HPV testing important in women?


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    MAY 29, 2014 7:30 AM PDT

    Is Cervical Cancer a preventable Disease in women? The role of HPV as a screening test.


    Specialty

    Laboratory Testing

    Clinical Diagnostics

    Health

    Immunology

    Medicine

    Infectious Disease

    Cell Biology

    Research

    Clinical Research

    Microbiology

    Clinical Medicine

    Pcr/rt-Pcr/real-Time Pcr

    Clinical Oncology

    Cancer Diagnostics

    Finabio

    Geography

    North America75%

    Asia13%

    Europe13%

    Registration Source

    Website Visitors100%

    Job Title

    Medical Laboratory Technician40%

    Facility/Department Manager40%

    Scientist20%

    Organization

    Hospital25%

    Clinical Laboratory25%

    Ambulatory Care25%

    Animal Hospital13%

    Manufacturer - Other13%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more